Can you take Wegovy with warfarin?

Jump to: What the evidence says | How Wegovy can affect warfarin | Weight loss and warfarin dosing | INR monitoring | Foods to focus on | Physical activity | When to speak to your GP | FAQs | Take home message

You can take Wegovy (semaglutide) alongside warfarin. One study found no clinically significant interaction between the two medications, with warfarin absorption and INR (a measure of how quickly our blood clots) response essentially unchanged.²

However, warfarin is a narrow therapeutic index drug, meaning small changes in its levels can have meaningful effects on blood clotting.

There are two indirect reasons why your prescriber should monitor your INR more closely when you start Wegovy: weight loss can change how much warfarin your body needs, and changes in appetite can affect your vitamin K intake.

What the evidence says

The most relevant evidence is an interaction study by Hausner and colleagues, published in Clinical Pharmacokinetics in 2017.²

This study gave healthy subjects a single 25 mg dose of warfarin, along with subcutaneous semaglutide at steady state.

The INR response ratio was 1.05 (90% CI 0.87-1.28), and the maximum INR response ratio was 1.04, both well within the 0.80-1.25 boundary that defines ‘no effect’.²

A separate study confirmed the same finding with oral semaglutide. Baekdal and colleagues found no apparent effects on warfarin exposure or INR response when oral semaglutide 20 mg was co-administered with warfarin.³

A 2024 conference abstract analysing 28 patients on warfarin alongside a GLP-1 receptor agonist found that time in therapeutic range was 59% before starting the GLP-1 and 60% after, with no bleeding events reported.⁴

How Wegovy can affect warfarin

Delayed gastric emptying

Semaglutide slows the rate at which our stomach empties after eating, which is one of the ways it helps to reduce appetite.

This delayed emptying can also affect how quickly other oral medications are absorbed. In the Hausner study, warfarin’s time to peak blood level was delayed when taken with semaglutide.²

However, the total amount of warfarin absorbed didn’t change. The drug still got into the bloodstream; it just took slightly longer. This is why the study concluded there was no clinically significant interaction.

Weight loss and INR changes

As you lose weight on Wegovy, your warfarin dose may need to be adjusted. People with obesity tend to need higher warfarin doses.

Research found that obese patients require approximately 20% higher weekly doses than those at a healthy weight.⁵

This means that as you lose weight, the same warfarin dose may produce a stronger anticoagulant effect. Your INR could rise, increasing the risk of bleeding.

Changes in vitamin K intake

Wegovy reduces appetite, so you’ll likely eat less overall. If this includes eating fewer green vegetables, your vitamin K intake could drop.

Vitamin K is essential for blood clotting, and warfarin works by blocking vitamin K’s effect. A sudden reduction in vitamin K intake can make warfarin more potent, pushing your INR higher.

Weight loss and warfarin dosing

Warfarin dosing is influenced by body weight in several ways. Fat tissue affects the volume of distribution of the drug, and changes in body composition alter how warfarin is metabolised.

The Wegovy SmPC acknowledges this. It recommends frequent INR monitoring when semaglutide is started alongside coumarin anticoagulants (the drug class that includes warfarin).¹

There have also been post-marketing reports of decreased INR in patients taking semaglutide alongside acenocoumarol, another coumarin anticoagulant.¹ This highlights that INR can shift in either direction, making monitoring essential.

Your warfarin dose may need to be adjusted as you lose weight, and your anticoagulant clinic needs to know you’ve started Wegovy.

INR monitoring

UK guidance recommends that INR should be tested within three to five days of starting any medication that could potentially interact with warfarin.⁶

When starting Wegovy, more frequent INR checks are sensible for the first few weeks.

After that, the key periods to watch are during dose escalations (every four weeks during titration) and whenever you notice significant weight changes.

A reasonable monitoring plan might include:

• INR check within three to five days of starting Wegovy
• Additional INR checks at each dose escalation step
• More frequent monitoring during periods of rapid weight loss
• Returning to your usual schedule once your weight and Wegovy dose have stabilised

Your anticoagulant clinic will tailor this schedule to your individual situation. Inform them when you start Wegovy so they can adjust your monitoring schedule.

Foods to focus on

Managing your diet while taking both Wegovy and warfarin requires balancing two priorities: eating a diet based on nutrient-dense whole foods while losing weight, and maintaining consistent vitamin K intake to keep your INR stable.

You don’t need to avoid vitamin K on warfarin

A common misconception is that people on warfarin should avoid vitamin K-rich foods entirely, but that’s not the case.

A randomised controlled trial found that consistent vitamin K supplementation (150 mcg per day) actually improved INR stability, increasing time in target range by 28%.⁷

Rather than avoiding vitamin K, the guidance is to eat similar amounts of vitamin K each day. Sudden changes, either eating much more or much less, are what cause problems with your INR.

High vitamin K foods to eat consistently

These foods are high in vitamin K. You don’t need to avoid them, but try to eat similar amounts each week:

• Leafy greens: spinach, kale, broccoli, Brussels sprouts, cabbage
• Green beans, asparagus, peas
• Herbs: parsley, basil, coriander (in cooking quantities)
• Extra virgin olive oil and cold-press rapeseed oil

How to ensure you’re eating enough vitamin K

When you’re eating less overall, there’s a risk of unintentionally eating less vitamin K, which could affect your INR. To manage this:

• Include a small portion of green vegetables with at least one meal each day, even a handful of spinach or a few broccoli florets
• If nausea is making it hard to eat vegetables, try them in smoothies, soups, or soft-cooked forms
• Keep your vegetable intake as consistent as possible day to day, rather than having large amounts some days and none on others
• Tell your anticoagulant clinic if your diet has changed significantly since starting Wegovy

Protein and complex carbohydrates

As you’ll be eating less on Wegovy, it’s essential to eat nutrient-dense protein and carbohydrate sources. Focus on:

• Lean protein at every meal: chicken, turkey, fish, eggs, tofu, lentils
• Oily fish (salmon, mackerel) for omega-3 fatty acids and heart health
• High-fibre complex carbohydrates: oats, wholegrain or sourdough bread, brown rice, sweet potato
• Dairy or fortified alternatives for calcium and vitamin D

Foods to limit

• Alcohol, even moderate intake, can affect INR and increase bleeding risk. If you do drink, keep it consistent and within guidelines.
• Cranberry juice, as there’s evidence that it can increase the anticoagulant effect of warfarin
• Ultra-processed foods, which are calorie-dense and nutrient-poor
• Sugary drinks and fruit juice

Physical activity

Regular movement is important for cardiovascular health, particularly if you’re taking warfarin for a heart-related condition like atrial fibrillation.

Being on an anticoagulant does require some practical considerations around activity choices, but it shouldn’t stop you from being active.

The most important thing is finding a movement you enjoy and can do regularly. Any activity is better than none, and building small, consistent habits matters more than hitting specific targets.

Getting started

If you’re not currently active, start small. A 10-minute walk after a meal is a practical first step, and research on habit formation suggests that linking a new behaviour to an existing routine (like walking after dinner) helps it become automatic over time.⁸

From there, gradually do a little more as it feels manageable. You might extend your walk by five minutes, add a second walk during the day, or try a different activity.

The goal is to build a routine you can sustain in the long term, not to follow a programme that feels overwhelming that you give up after a few weeks.

Good options while on warfarin include walking, swimming, cycling (stationary or outdoor with appropriate safety equipment), yoga, pilates, and low-impact fitness classes.

Building strength

Resistance training helps maintain muscle mass during weight loss on Wegovy and supports bone health. It’s safe on warfarin as long as you take sensible precautions:

• Start with bodyweight exercises like squats, wall push-ups, or seated rows
• You could try ‘snacking’ on exercise, doing squats while you wait for the kettle to boil, or calf raises while you’re on a meeting that doesn’t require you to have your camera on
• Use machines rather than free weights initially, as they’re easier to control
• Avoid exercises that risk heavy impact or falls
• Build up gradually over weeks and months

Higher-risk activities

Because warfarin increases bleeding risk, some activities need more care:

• Contact sports (rugby, football, martial arts) carry a higher risk of bruising and internal bleeding
• Activities with a high risk of falls (alpine skiing, horse riding) should be approached cautiously
• If you experience a significant knock or fall during exercise, monitor for unusual bruising and contact your GP if concerned
• Carry medical identification indicating you take warfarin, particularly during outdoor activities

If you increase your activity level significantly, let your anticoagulant clinic know, as regular exercise can affect your warfarin requirements.⁹

When to speak to your GP

Contact your GP, anticoagulant clinic, or prescriber if you experience:

• Unusual bruising or bruising that appears without an obvious cause
• Blood in your urine or stools, or black tarry stools
• Bleeding gums or nosebleeds that are difficult to stop
• Prolonged bleeding from cuts or wounds
• Severe headache, dizziness, or weakness (potential signs of internal bleeding)
• Persistent nausea or vomiting that affects your ability to take warfarin consistently
• Significant or rapid weight loss, which may require a warfarin dose adjustment
• Feelings of anxiety or low mood related to managing your medications

If you experience severe or uncontrollable bleeding, call 999 or go to A&E immediately.

Frequently asked questions

Is it safe to take Wegovy with warfarin?

Yes, based on current evidence. Two formal pharmacokinetic studies found no clinically significant interaction between semaglutide and warfarin.^2,3

The Wegovy SmPC doesn’t list warfarin as a contraindication but recommends frequent INR monitoring when starting semaglutide.¹

Will Wegovy affect my INR levels?

The direct effect on INR appears minimal.² However, weight loss from Wegovy may indirectly affect your INR over time. As you lose weight, your body may need less warfarin, and your INR could rise if the dose isn’t adjusted.

Do I need more frequent blood tests when starting Wegovy?

Yes. It’s sensible to have your INR checked within three to five days of starting Wegovy and at each dose escalation step.⁶

Once your dose and weight have stabilised, you can likely return to your usual schedule.

How does weight loss affect warfarin dosing?

People with a higher body weight generally need higher warfarin doses. Research shows that obese patients require approximately 20% higher weekly doses than those at a healthy weight.⁵ As you lose weight, your current dose may become relatively stronger.

Do I need to avoid vitamin K-rich foods?

No. It’s recommended to eat similar amounts of green vegetables each week rather than avoid them entirely.

A randomised controlled trial found that consistent vitamin K intake actually improved INR stability.⁷ Tell your anticoagulant clinic if your diet changes significantly.

Can semaglutide delay warfarin absorption?

Yes. Semaglutide slows gastric emptying, thereby delaying the time to peak warfarin levels.² However, the total amount absorbed remains unchanged, so the overall anticoagulant effect isn’t reduced.

What does the Wegovy prescribing information say about warfarin?

The SmPC recommends frequent INR monitoring when starting semaglutide in patients taking coumarin anticoagulants such as warfarin.¹ It also notes post-marketing reports of altered INR with acenocoumarol.

Should I change when I take warfarin after starting Wegovy?

There’s no specific guidance recommending this. Semaglutide’s effects on gastric emptying are continuous at steady state rather than linked to the injection day. Continue taking warfarin at your usual time.

Can I take Wegovy if I’m on a DOAC instead of warfarin?

DOACs (such as apixaban, rivaroxaban, edoxaban) don’t require INR monitoring and have fewer food interactions than warfarin. There’s limited published data on GLP-1 receptor agonists and DOACs specifically. Speak to your prescriber.

Can I get Wegovy on the NHS if I take warfarin?

Taking warfarin doesn’t disqualify you from NHS access to Wegovy. NICE TA875 recommends semaglutide for weight management in eligible adults.¹⁰

Your GP can refer you to a specialist weight management service, and your anticoagulant status would be managed alongside.

Take home message

Wegovy can be taken alongside warfarin. Research shows no clinically significant direct interaction between semaglutide and warfarin.

The main consideration is the indirect effect of weight loss on warfarin dosing, as your weight decreases, your warfarin dose may need reducing to keep your INR in range.

Maintaining consistent vitamin K intake is particularly important when Wegovy reduces your appetite.

Aim to include a portion of green vegetables each day, and tell your anticoagulant clinic about any significant dietary changes.

Inform your anticoagulant clinic when you start Wegovy, have your INR checked within the first week, and continue with more frequent monitoring during dose escalation and active weight loss.

Second Nature’s programme combines medication support with personalised nutrition guidance from registered dietitians and nutritionists, built around a balanced plate of vegetables, protein, complex carbohydrates, and healthy fats.

A peer-reviewed study published in JMIR Formative Research found that active subscribers on Second Nature’s semaglutide-supported programme lost an average of 19.1% of their body weight at 12 months, with 77.7% achieving at least 10% weight loss.¹¹

This support can help you balance your dietary needs for both weight management and stable anticoagulation.

References

1. Electronic Medicines Compendium. (2026). Wegovy 0.25 mg solution for injection in pre-filled pen: Summary of Product Characteristics.
2. Hausner, H. et al. (2017). Effect of semaglutide on the pharmacokinetics of metformin, warfarin, atorvastatin and digoxin in healthy subjects. Clinical Pharmacokinetics.
3. Baekdal, T.A. et al. (2019). Effect of oral semaglutide on the pharmacokinetics of lisinopril, warfarin, digoxin, and metformin in healthy subjects. Clinical Pharmacokinetics.
4. Anjum, P. et al. (2024). Warfarin and GLP-1 receptor agonist interaction effects on time in therapeutic range. Blood (ASH conference abstract).
5. Alshammari, A. et al. (2020). Warfarin dosing requirement according to body mass index. Cureus.
6. NHS Specialist Pharmacy Service. Warfarin monitoring.
7. Sconce, E. et al. (2007). Vitamin K supplementation can improve stability of anticoagulation for patients with unexplained variability in response to warfarin. Blood.
8. Lally, P. et al. (2010). How are habits formed: modelling habit formation in the real world. European Journal of Social Psychology, 40(6), 998-1009.
9. Rouleau-Mailloux, E. et al. (2016). Impact of regular physical activity on weekly warfarin dose requirement. Journal of Thrombosis and Thrombolysis.
10. NICE. (2023). Semaglutide for managing overweight and obesity. Technology Appraisal TA875.
11. Richards, R. et al. (2025). A remotely delivered, semaglutide-supported weight management program: 12-month outcomes from a retrospective service evaluation. JMIR Formative Research, 9(1), e72577.